VEGFA and macular retinal edema: In addition, the DEX implant is also preferred by cost-benefit analyses, considering that it has already been demonstrated that an improvement in macular edema can be achieved with a lower number of DEX implants compared to the use of anti-VEGF drugs, thus resulting in lower costs [94,100,101,102,103].